Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Vascular Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Olin, J. W
Right arrow Articles by Griffiths, R. I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olin, J. W
Right arrow Articles by Griffiths, R. I
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study

Jeffrey W Olin

Department of Vascular Medicine, Cleveland Clinic Foundation, Cleveland, OH

Kathleen M Beusterien

Covance Health Economics and Outcomes Services Inc., Washington, DC

Mary Beth Childs

Department of Vascular Medicine, Cleveland Clinic Foundation, Cleveland, OH

Caroline Seavey

Covance Health Economics and Outcomes Services Inc., Washington, DC

Linda McHugh

Department of Vascular Medicine, Cleveland Clinic Foundation, Cleveland, OH

Robert I Griffiths

Covance Health Economics and Outcomes Services Inc., Washington, DC, Program for Medical Technology and Practice Assessment, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Venous stasis ulcers (VSU) account for approximately 80-90% of lower extremity ulcerations. Given their prevalence and chronic nature, VSU are thought to impose a significant economic burden on Medicare (the USA's largest health insurance program) and other third party payers. However, comprehensive studies on the costs of VSU treatment are lacking. The objective of this study therefore was to examine comprehensively the direct medical costs of treating patients with a VSU in routine clinical practice.

A cohort of 78 patients who presented with a VSU to the Cleveland Clinic Foundation (CCF), a large primary and tertiary referral center, was studied retrospectively. All inpatient and out-patient costs related to VSU treatment that were incurred during the year following VSU presentation or until the ulcer healed, whichever occurred first, were quantified. A total of 71 (91%) patients healed during the study. The average duration of follow-up was 119 days (median: 84 days). The average number of visits per patient was seven (range: 2 to 57). A total of 14 (18%) patients underwent 18 hospitalizations for VSU care. The average total medical cost per patient was $9685 (median: $3036). Home health care, hospitalizations and home dressing changes accounted for 48%, 25% and 21% of total costs, respectively. Total costs were related to duration of active therapy, ulcer size and the presence of at least one comorbidity (p,0.05).

VSU are costly to manage, especially when time to healing is prolonged. The present findings reflect an underestimate of VSU costs since indirect costs were not examined. Time absent from work, forced early retirement, loss of functional independence and unquantifiable suffering may be additional factors that contribute to the overall burden of VSU.

Key Words: economics • health care costs • medical resource utilization • venous stasis ulcer

Vascular Medicine, Vol. 4, No. 1, 1-7 (1999)
DOI: 10.1177/1358836X9900400101


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
INT J LOW EXTREM WOUNDSHome page
R. Frykberg, E. Tierney, A. Tallis, and T. Klotzbach
Cell Proliferation Induction: Healing Chronic Wounds Through Low-Energy Pulsed Radiofrequency
International Journal of Lower Extremity Wounds, March 1, 2009; 8(1): 45 - 51.
[Abstract] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
G. Danielsson, B. Arfvidsson, B. Eklof, R. L. Kistner, E. M. Masuda, and D. T. Sato
Reflux from Thigh to Calf, the Major Pathology in Chronic Venous Ulcer Disease: Surgery Indicated in the Majority of Patients
Vascular and Endovascular Surgery, May 1, 2004; 38(3): 209 - 219.
[Abstract] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
S. L. Drinkwater, A. Smith, and K. G. Burnand
What Can Wound Fluids Tell Us About the Venous Ulcer Microenvironment?
International Journal of Lower Extremity Wounds, September 1, 2002; 1(3): 184 - 190.
[Abstract] [PDF]